Susan E Morano's most recent trade in Boston Scientific Corp. was a trade of 2,081 Common Stock done . Disclosure was reported to the exchange on May 8, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Boston Scientific | Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 2,081 | 6,034 (0%) | 0% | 0 | Common Stock | |
Boston Scientific | Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 605 | 6,639 (0%) | 0% | 0 | Common Stock | |
Boston Scientific | Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 1,450 | 3,532 (0%) | 0% | 0 | Common Stock | |
Boston Scientific | Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 1,450 | 3,532 | - | - | Deferred Stock Units | |
Boston Scientific | Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 421 | 3,953 (0%) | 0% | 0 | Common Stock | |
Boston Scientific | Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 421 | 3,953 | - | - | Deferred Stock Units | |
Boston Scientific | Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 1,626 | 1,626 | - | - | Deferred Stock Units | |
Boston Scientific | Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 1,626 | 1,626 (0%) | 0% | 0 | Common Stock | |
Boston Scientific | Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 456 | 2,082 | - | - | Deferred Stock Units | |
Boston Scientific | Susan E. Morano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 456 | 2,082 (0%) | 0% | 0 | Common Stock |